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Abstract
We evaluated changes in the epidemiology of catheter-related
bloodstream infections (CRBSIs) between 1996 and 2012 in a
tertiary care centre in Israel. The cohort included 1754 episodes
of CRBSI. The incidence of CRBSIs decreased throughout the
study period, whereas 30-day mortality following bacteraemia
increased. There was a linear shift toward predominance of
Gram-negative bacilli throughout the study period (p for
trend<0.001). In 1996, 68% (68/100) of CRBSIs were caused by
Gram-positive cocci, whereas in 2012 77.8% (28/26) were caused
by Gram-negative bacilli. The shift towards Gram-negative CRBSIs
and the associated mortality mandates that empirical treatment
for CRBSIs be directed by local epidemiology.
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Introduction
Staphylococci are considered the most common pathogens
among patients with catheter-related bloodstream infections
(CRBSIs). Guidelines recommend empirical glycopeptides
routinely, whereas antibiotics directed against Gram-negative
bacilli are recommended more selectively, targeting local
epidemiology, critically ill or neutropenic patients. In recent
years, the prevalence of Gram-negative organisms among
CRBSIs might be increasing, reinforcing the need for their
empirical coverage. We evaluated changes in the epidemiology
of CRBSI during the period 1996–2012.
We retrospectively included children and adults with
CRBSIs between 1996 and 2012 in the Rambam Health Care
Campus, Haifa, Israel, a 942-bed primary and tertiary, univer-
sity-afﬁliated hospital. The CRBSIs were identiﬁed by growth
of the same microorganism (type and antibiotic susceptibility)
from the catheter tip and from at least one blood culture
within 7 days. Throughout the study period, blood cultures
were recommended for suspected sepsis and bacteraemia and
local hospital guidelines for prevention of CRBSIs existed. An
active bundle approach for CRBSI prevention [1] with
surveillance and reporting of catheter-associated bloodstream
infections was initiated in 2010 in the hospital’s intensive care
units (ICUs). Silver-sulphadiazine-chlorhexidine-impregnated
catheters entered routine use in the adult medical-surgical
ICU (18 beds) and paediatric ICU (ten beds) in 2004.
Semi-quantitative catheter tip cultures were performed on
sheep blood agar plates (Hy Laboratories Ltd, Rehovot, Israel),
using the roll plate method with a cut-off of 15 CFU [2]. Blood
cultures were performed using the automated Bac-T-Alert
(Biomerieux, Marcy l’Etoile, France) initially and Bactec 9240
(Becton Dickinson, Franklin Lakes, NJ, USA) systems later.
Bacterial isolates were identiﬁed to the species level using
manual biochemical tests and the VITEK-2 system (bioMerie-
ux).
Incidence of CRBSIs was expressed per 1000 hospital-days
[3]. Signiﬁcance was tested using the chi-square p for trends.
The study was approved by the local ethics committee.
The cohort included 1754 episodes of CRBSI caused by
1859 bacteria (105 episodes were polymicrobial); 17.4% of
episodes occurred in children (median age 1 year, range 0–18)
and 82.6% among adults (mean age 58.4 years, SD 19.4). There
was no signiﬁcant change in patients’ age throughout the study
years. The incidence of CRBSI episodes per year decreased
signiﬁcantly and linearly throughout the study years (p <001
for trend). The incidence was 0.52/1000 hospital-days between
1996 and 2003 versus 0.21/1000 hospital-days between 2004
and 2012.
We observed a gradual shift between 1996 and 2012
toward a predominance of Gram-negative bacilli, (p <0.001,
Fig. 1). In 1996, 68% (68/100) of CRBSIs were caused by
Gram-positive cocci, whereas between 2010 and 2012, 76%
(94/123) were caused by Gram-negative bacilli. Between 2010
and 2012, Pseudomonas aeruginosa was the most common
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pathogen (22%), followed by Klebsiella sp. (19.5%), Staphylococ-
cus aureus (16.3%) and Acinetobacter sp. (14.6%) (Table 1). Of
the Gram-negatives, 47% (43/92) were resistant to ceftazidime,
39% (31/80) to piperacillin-tazobactam and 24% (22/93) to
imipenem. Of the S. aureus CRBSIs, 55% (11/20) were
methicillin-resistant. Similar trends showing a change from
predominance of Gram-positive bacteria to predominance of
Gram-negative bacteria were observed in the paediatric and
adult subpopulations, when the analysis was limited to the ICU
and among haematological cancer patients. The percentage of
CRBSIs acquired in the adult and paediatric ICUs decreased
from 36.4% (467/1283) between 1996 and 2003 to 22.2% (128/
576) after introduction of the impregnated catheters to these
ICUs. Thirty-day mortality increased concomitantly with the
shift towards Gram-negative bacteria, averaging 6.6% (58/879
patients, only patients’ ﬁrst episode counted) in the ﬁrst half of
the study and 27.2% (97/356 patients) in the second half
(p <001 for trend along the years).
During a 17-year period the incidence of CRBSIs has
dropped signiﬁcantly and bacteriology has changed from
predominance of staphylococci to predominance of Gram-neg-
ative bacilli. In the last 3 years, approximately 75% of CRBSIs
were caused by Gram-negative bacilli. Concomitantly, 30-day
mortality following CRBSIs increased.
In a 700-bed university hospital in Barcelona, Spain, the
proportion of Gram-negatives increased from 4.7% in 1991 to
40.2% in 2008 [4]. Another hospital in Barcelona reported a
shift towards Gram-negative CRBSIs in their ICU but not in
other wards, attributing the change to implementation of a
bundled strategy for CRBSI prevention, which preferentially
affected Gram-positive CRBSIs [5]. In a large general hospital
in Madrid, there was an average annual increase of Gram-neg-
ative CRBSIs of 8.9% between 2003 and 2010, whereas the
incidence of Gram-positives decreased by 25% [3]. The
National Healthcare Safety Network reported on pathogen
distribution of central line-associated bloodstream infections in
the USA. Between 2006 and 2007, 17.7% of central line-asso-
ciated bloodstream infections were caused by Gram-negative
bacilli, [6] and between 2009 and 2010 this proporrtion was
25.6% [7]. Hence, a shift towards Gram-negative central
catheter infections might be occurring in several locations,
although near dominance of Gram-negatives, as in our centre,
has not been previously reported.
We included by deﬁnition only those CRBSIs in which the
catheter was extracted and we did not have information on
other sources of infection. However, the same process for
CRBSI identiﬁcation was applied throughout the years, so the
data should reﬂect trends over time. We had no data on
central catheter site. Femoral placement predisposes to
Gram-negative infections; however, through the years the
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FIG. 1. Percentage of Gram-positive cocci and Gram-negative bacilli per year among CRBSIs.
TABLE 1. Pathogen distribution among catheter-related
bloodstream infections during 2010–2012
N isolates Percent
Staphylococcus aureus 20 16.3
Enterococcus sp. 8 6.5
Coagulase-negative staphylococcus 1 0.8
Total Gram-positive 29 24
Acinetobacter sp. 18 14.6
Escherichia coli 4 3.3
Enterobacter sp. 6 4.9
Klebsiella sp. 24 19.5
Proteus sp. 6 4.9
Providencia sp. 4 3.3
Pseudomonas aeruginosa 27 22.0
Serratia sp. 4 3.3
Stenotrophomonas maltophilia 1 0.8
Total Gram-negative 94 76
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use of femoral catheters in our centre declined. No change in
the methods of coagulase-negative staphylococci isolation or
reporting occurred during these years. Possible explanations
for the increase in Gram-negative CRBSIs include a 50%
increase in the number of haematological bone marrow
transplantations, as well as the number of beds in the hospital
ICUs. Silver sulphadiazine-chlorhexidine-impregnated cathe-
ters might shift CRBSI epidemiology towards Gram-negative
infections, [5] although most CRBSIs throughout the study
period occurred outside the ICUs using these catheters The
increase in mortality is probably multifactorial, related mostly
to changes in patient case-mix, although the contribution of
inappropriate empirical antibiotic treatment [8] and less
effective deﬁnitive treatment of multidrug-resistant Gram-neg-
ative isolates [9] cannot be ruled out. A recent study from
Spain showed similar high rates of mortality among patients
with P. aeruginosa CRBSI, the most common pathogen in our
institute [10].
In conclusion, we report a signiﬁcant shift in the epidemi-
ology of CRBSIs towards a predominance of Gram-negative
CRBSIs. The percentage of methicillin-resistant staphylococci
out of all CRBSIs was <10%, questioning the need for empirical
vancomycin for suspected CRBSIs in our setting. Conversely,
Gram-negative CRBSIs are associated with signiﬁcant mortality
and empirical treatment must address their increasing prev-
alence. Empirical treatment of CRBSIs should be directed by
local epidemiology.
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